Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) — Cash Flow Reinvestment Rate
Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) has a Cash Flow Reinvestment Rate of 0.19x as of September 2025, reinvesting CN¥54.40 Million (capex CN¥54.40 Million ) from operating cash flow of CN¥281.88 Million. Check how high is Shaanxi Meibang Pharmaceutical Group Co 's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shaanxi Meibang Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for Shaanxi Meibang Pharmaceutical Group Co Ltd across 7 annual periods. Explore Shaanxi Meibang Pharmaceutical Group Co cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Shaanxi Meibang Pharmaceutical Group Co Ltd (2017–2024)
Year-by-year capital reinvestment analysis for Shaanxi Meibang Pharmaceutical Group Co Ltd. For live market cap and broader valuation context, see market value of Shaanxi Meibang Pharmaceutical Group Co .
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.92x | CN¥539.05 Million | CN¥280.40 Million | CN¥158.81 Million | ▲ +123.3% |
| 2023 | 0.86x | CN¥288.20 Million | CN¥334.79 Million | CN¥203.69 Million | ▼ -24.3% |
| 2022 | 1.14x | CN¥143.69 Million | CN¥126.41 Million | CN¥109.29 Million | ▼ -19.1% |
| 2020 | 1.40x | CN¥105.20 Million | CN¥74.88 Million | CN¥61.71 Million | ▲ +218.4% |
| 2019 | 0.44x | CN¥56.69 Million | CN¥128.45 Million | CN¥33.78 Million | ▼ -78.5% |
| 2018 | 2.06x | CN¥34.86 Million | CN¥16.96 Million | CN¥34.86 Million | ▲ +244.2% |
| 2017 | 0.60x | CN¥17.56 Million | CN¥29.41 Million | CN¥17.56 Million | — |